Tofacitinib efficacy, patient-reported outcomes and safety in patients with psoriasis and a medical history of psoriatic arthritis: Pooled analysis of two Phase III studies

被引：2
|
作者：
Bachelez, H. [1 ,2 ]
Griffiths, C. E. M. [3 ,4 ]
Papp, K. A. [5 ,6 ]
Hall, S. [7 ]
Merola, J. F. [8 ]
Feldman, S. R. [9 ]
Khraishi, M. [10 ]
Tan, H. [11 ]
Fallon, L. [12 ]
Cappelleri, J. C. [11 ]
Bushmakin, A. G. [11 ]
Young, P. [13 ]
机构：
[1] Hop St Louis, AP HP, Dept Dermatol, Paris, France
[2] Univ Paris, Imagine Inst, Unite INSERM U1163, Paris, France
[3] Univ Manchester, NIHR Manchester Biomed Res Ctr, Salford Royal Hosp, Dermatol Ctr, Manchester, England
[4] Kings Coll Hosp London, Kings Coll London, Dept Dermatol, London, England
[5] Prob Med Res & Alliance Clin Trials Inc, Waterloo, ON, Canada
[6] Univ Toronto, Toronto, ON, Canada
[7] Malvern, Res, Melbourne, Australia
[8] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[9] Wake Forest Univ, Sch Med, Winston Salem, NC USA
[10] Mem Univ Newfoundland, St John, NF, Canada
[11] Pfizer Inc, Groton, CT USA
[12] Pfizer Inc, Kirkland, PQ, Canada
[13] Pfizer Inc, 500 Arcola Rd, Collegeville, PA 19426 USA
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2024年 / 38卷 / 07期
关键词：
JANUS KINASE INHIBITOR; PLACEBO;
D O I：
10.1111/jdv.19701
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E557 / E561
页数：5
相关论文
共 50 条
  • [21] IMPROVED PATIENT-REPORTED OUTCOMES IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH ABATACEPT: RESULTS FROM A PHASE III TRIAL
    Strand, V.
    Alemao, E.
    Lehman, T.
    Johnsen, A.
    Banerjee, S.
    Ahmad, H.
    Mease, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 687 - 687
  • [22] Improved Patient-Reported Outcomes in Psoriatic Arthritis Patients Treated with Abatacept: Results from a Phase III Trial
    Strand, Vibeke
    Alemao, E.
    Lehman, T.
    Johnsen, A.
    Banerjee, S.
    Ahmad, H. A.
    Mease, Philip J.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [23] Relationships Between Minimal Disease Activity and Patient-Reported Outcomes in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies
    Helliwell, Philip
    Bushmakin, Andrew
    Gladman, Dafna
    FitzGerald, Oliver
    Fallon, Lara
    Cappelleri, Joseph
    Hsu, Ming-Ann
    Coates, Laura
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [24] IMPACT OF PATIENT PERCEPTION OF PSORIASIS AND PSORIATIC ARTHRITIS SEVERITY ON PATIENT-REPORTED OUTCOMES: AN ANALYSIS FROM THE ADELPHI DATABASE
    Boehncke, W. -H.
    Piercy, J.
    Chen, S.
    Hojnik, M.
    Ganz, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1161 - 1161
  • [25] Relationships of dermatologic symptoms and quality of life in patients with psoriatic arthritis: analysis of two tofacitinib phase III studies
    Taylor, Peter C.
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Young, Pamela
    Germino, Rebecca
    Merola, Joseph F.
    Yosipovitch, Gil
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (05) : 2614 - 2620
  • [26] Treatment with SDZ-ADL, an Adalimumab Biosimilar, in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis: Results of Patient-Reported Outcome Measures from Two Phase III Studies (ADMYRA and ADACCESS)
    Blauvelt, Andrew
    Leonardi, Craig L.
    Gaylis, Norman
    Jauch-Lembach, Julia
    Balfour, Alison
    Lemke, Lena
    Hachaichi, Sohaib
    Brueckmann, Ines
    Festini, Teodora
    Wiland, Piotr
    BIODRUGS, 2021, 35 (02) : 229 - 238
  • [27] Treatment with SDZ-ADL, an Adalimumab Biosimilar, in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis: Results of Patient-Reported Outcome Measures from Two Phase III Studies (ADMYRA and ADACCESS)
    Andrew Blauvelt
    Craig L. Leonardi
    Norman Gaylis
    Julia Jauch-Lembach
    Alison Balfour
    Lena Lemke
    Sohaib Hachaichi
    Ines Brueckmann
    Teodora Festini
    Piotr Wiland
    BioDrugs, 2021, 35 : 229 - 238
  • [28] Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by History of Cigarette Smoking
    Ogdie, Alexis
    Kristensen, Lars Erik
    Soriano, Enrique R.
    Akar, Servet
    Sun, Yanhui
    Gruben, David
    Fallon, Lara
    Kinch, Cassandra D.
    Gladman, Dafna
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2057 - 2060
  • [29] Effects of Tofacitinib On Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis Receiving Stable-Dose Methotrexate: Results of Two Phase 3 Studies
    Burmester, Gerd R.
    van der Heijde, Desiree
    Strand, Vibeke
    Zerbini, Cristiano A. F.
    Connell, Carol A.
    Mebus, Charles A.
    Zwillich, Samuel H.
    Bradley, John D.
    Gruben, David
    Wallenstein, Gene
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S549 - S549
  • [30] Tofacitinib in active ulcerative colitis: Analysis of efficacy based on patient-reported outcomes
    Panes, J.
    Su, C.
    Bushmakin, A. G.
    Cappelleri, J. C.
    Mamolo, C.
    Healey, P.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S51 - S51
12345